Roche Holding reported CHF14.74B in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Alcon AG ALC:SW USD 2.14B 77M
Amgen AMGN:US USD 6.65B 58M
Artemis Alpha ATS:LN GBP -25863000 16.53M
AstraZeneca AZN:LN USD 10.98B 211M
Bayer BAYN:GR EUR 11.28B 1.54B
Biogen BIIB:US USD 2.51B 80.6M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Eli Lilly And LLY:US USD 6.94B 453.6M
Fresenius FRE:GR EUR 10.46B 441M
Fresenius Medical Care FME:GR EUR 5.1B 339M
Galapagos GLPG:NA EUR 148.04M 473K
Genmab GEN:DC DKK 4.09B 925M
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Lonza Group LONN:SW CHF 2.98B 115M
Merck MRK:GR EUR 5.81B 238M
Merk MRK:US USD 14.96B 366M
Novartis NOVN:VX USD 12.84B 243M
Orion ORNBV:FH EUR 491.8M 208.1M
Pfizer PFE:US USD 22.64B 5.1B
Philips PHIA:NA EUR 4.31B 133M
Recordati REC:IM EUR 485.05M 11.94M
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Roche Holding ROG:VX CHF 14.74B 1.7B